triazoles has been researched along with Trypanosomiasis, African in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Boechat, N; Castelo-Branco, FS; França, RRF; Hoelz, LVB; Menozzi, CAC | 1 |
Abbasi Shiran, J; Ghanbari, M; Mohammadnejadi, E; Razzaghi-Asl, N | 1 |
Aziz, N; Barnes, W; Barrett, MP; Chen, YL; Cheung, H; Cortopassi, WA; Deniston, C; Diagana, TT; Francisco, AF; Gable, JE; Ghafar, NA; Gould, MK; Jiricek, J; Johnson, N; Jumani, RS; Kaiser, M; Kelly, JM; Lakshminarayana, SB; Luu, C; Manjunatha, UH; Manoharan, V; Mäser, P; Mottram, JC; Myburgh, E; Ng, PS; Noeske, J; Osborne, C; Palkar, R; Patra, D; Rao, SPS; René, O; Ritchie, R; Saldivia, M; Sarko, C; Schenk, AD; Schmidt, RS; Thomas, B; Wagner, J; Walker, J; Wan, KF; Wartchow, C; Wiedemar, N | 1 |
Ballard, J; Barnes, SW; Biggart, A; Brock, A; Buckner, FS; Bursulaya, B; Davis, LC; Federe, G; Gao, MY; Gillespie, JR; Glynne, RJ; Groessl, T; Khare, S; Koh, HX; Lai, YH; Liang, F; Liu, X; Mathison, CJ; Mishra, PK; Molteni, V; Mottram, JC; Myburgh, E; Nagle, AS; Rao, SP; Rivera, IC; Shapiro, M; Spraggon, G; Stinson, M; Supek, F; Tan, JL; Tuntland, T; Venable, JD; Walker, JR; Wen, BG; Yeh, V | 1 |
Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS; Szular, J; Wilkinson, SR | 1 |
Blonski, C; Diez-Martinez, A; Jagu, E; Krauth-Siegel, RL; Labruère, R; Loiseau, PM; Pethe, S; Pomel, S; Ramiandrasoa, F | 1 |
Bonhivers, M; Courtois, P; Dacheux, D; Dauchy, FA; Daulouède, S; Landrein, N; Lauruol, F; Robinson, DR; Vincendeau, P | 1 |
Barrett, MP; Croft, SL | 1 |
2 review(s) available for triazoles and Trypanosomiasis, African
Article | Year |
---|---|
The Medicinal Chemistry of 3-nitro-1,2,4-triazoles: Focus on Infectious Diseases.
Topics: Animals; Chagas Disease; Chemistry, Pharmaceutical; Communicable Diseases; Humans; Leishmaniasis; Mycoses; Triazoles; Trypanosomiasis, African; Tuberculosis | 2021 |
Management of trypanosomiasis and leishmaniasis.
Topics: Administration, Oral; Africa; Amphotericin B; Antiprotozoal Agents; Benzamides; Boron Compounds; Chagas Disease; Drug Therapy, Combination; Humans; India; Leishmaniasis; Nitroimidazoles; Pentamidine; Triazoles; Trypanosomiasis, African | 2012 |
6 other study(ies) available for triazoles and Trypanosomiasis, African
Article | Year |
---|---|
Structural Insight into Privileged Heterocycles as Anti-
Topics: Animals; Chagas Disease; Humans; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis, African | 2023 |
Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections.
Topics: Animals; Chagas Disease; Cryoelectron Microscopy; DNA Topoisomerases, Type II; Drug Evaluation, Preclinical; Humans; Mice; Topoisomerase II Inhibitors; Triazoles; Trypanosoma; Trypanosomiasis, African | 2023 |
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
Topics: Animals; Chagas Disease; Chymotrypsin; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Kinetoplastida; Leishmaniasis; Mice; Molecular Structure; Molecular Targeted Therapy; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrimidines; Species Specificity; Triazoles; Trypanosomiasis, African | 2016 |
Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity.
Topics: Acetamides; Animals; Mice; Nitroreductases; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Trypanosomiasis, African | 2016 |
Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Topics: Animals; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; NADH, NADPH Oxidoreductases; Spermidine; Triazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |
Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
Topics: 14-alpha Demethylase Inhibitors; Animals; Anti-Bacterial Agents; Cytokinesis; Disease Models, Animal; Doxycycline; Eflornithine; Ergosterol; Humans; Mice; Nifurtimox; Phenotype; RNA Interference; Sterol 14-Demethylase; Triazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2016 |